comparemela.com

Latest Breaking News On - Immunomodulatory drugs - Page 3 : comparemela.com

Multiple Endocrine Neoplasia Treatment Market to Experience Substantial Growth of 6 Billion by 2030, Size, Share, Trends, Demand, Growth Rate and Key Players Analysis

Lifestyle changes may minimize inflammatory cascade associated with autoimmune disease

ORLANDO — Lifestyle modifications such as exercise and an anti-inflammatory diet can improve the well-being of patients being treated for autoimmune diseases, said a presenter at the 2022 Rheumatology Nurses Society Conference. George E. Munoz, MD, medical director of American Arthritis and Rheumatology Associates, and chief medical officer of the Oasis Institute, in Miami, discussed

Insights on Global Neurodegenerative Disease Market Size & Share to Reach USD 47911 88 Million by 2028, Exhibit a CAGR of 3 1% | Industry Trends, Value, Analysis & Forecast Report by Zion Market Research

Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022

SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, and IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, today jointly announced that the updated data from phase 1/2 study of Equecabtagene Autoleucel (Innovent R&D code: IBI326, IASO Bio R&D code: CT103A), a fully-human anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed and/or refractory multiple myeloma (R/R MM), was presented in the form of an oral presentation at the 27th European Hematology Association (EHA) Annual Meeting in Vienna on June 9-12, 2022

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.